ABN AMRO BANK NV-CVA (ABN.AS) Fundamental Analysis & Valuation

AMS:ABN • NL0011540547

27.11 EUR
-0.32 (-1.17%)
Last: Mar 6, 2026, 07:00 PM

This ABN.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ABN. ABN was compared to 106 industry peers in the Banks industry. ABN may be in some trouble as it scores bad on both profitability and health. ABN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. ABN.AS Profitability Analysis

1.1 Basic Checks

  • ABN had positive earnings in the past year.
  • Each year in the past 5 years ABN has been profitable.
  • In the past 5 years ABN reported 4 times negative operating cash flow.
ABN.AS Yearly Net Income VS EBIT VS OCF VS FCFABN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B 30B 40B

1.2 Ratios

  • ABN's Return On Assets of 0.49% is on the low side compared to the rest of the industry. ABN is outperformed by 72.64% of its industry peers.
  • ABN has a worse Return On Equity (7.53%) than 65.09% of its industry peers.
Industry RankSector Rank
ROA 0.49%
ROE 7.53%
ROIC N/A
ROA(3y)0.59%
ROA(5y)0.51%
ROE(3y)9.02%
ROE(5y)8%
ROIC(3y)N/A
ROIC(5y)N/A
ABN.AS Yearly ROA, ROE, ROICABN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 21.78%, ABN is in line with its industry, outperforming 44.34% of the companies in the same industry.
  • ABN's Profit Margin has been stable in the last couple of years.
  • The Operating Margin and Gross Margin are not available for ABN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 21.78%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.34%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABN.AS Yearly Profit, Operating, Gross MarginsABN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1

2. ABN.AS Health Analysis

2.1 Basic Checks

  • ABN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ABN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ABN has been reduced compared to 5 years ago.
  • The debt/assets ratio for ABN has been reduced compared to a year ago.
ABN.AS Yearly Shares OutstandingABN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
ABN.AS Yearly Total Debt VS Total AssetsABN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B

2.2 Solvency

  • ABN has a Debt/Equity ratio of 3.49. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 3.49, ABN is not doing good in the industry: 83.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.49
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.59%
ABN.AS Yearly LT Debt VS Equity VS FCFABN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ABN.AS Yearly Current Assets VS Current LiabilitesABN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. ABN.AS Growth Analysis

3.1 Past

  • The earnings per share for ABN have decreased by -8.89% in the last year.
  • The Earnings Per Share has been growing slightly by 7.87% on average over the past years.
  • The Revenue has decreased by -2.43% in the past year.
  • Measured over the past years, ABN shows a small growth in Revenue. The Revenue has been growing by 1.47% on average per year.
EPS 1Y (TTM)-8.89%
EPS 3Y7.87%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-2.43%
Revenue growth 3Y3.28%
Revenue growth 5Y1.47%
Sales Q2Q%0.85%

3.2 Future

  • Based on estimates for the next years, ABN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.16% on average per year.
  • The Revenue is expected to grow by 2.70% on average over the next years.
EPS Next Y12.28%
EPS Next 2Y16.56%
EPS Next 3Y14.11%
EPS Next 5Y11.16%
Revenue Next Year6.03%
Revenue Next 2Y6.01%
Revenue Next 3Y5.43%
Revenue Next 5Y2.7%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABN.AS Yearly Revenue VS EstimatesABN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ABN.AS Yearly EPS VS EstimatesABN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4

5

4. ABN.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.02, which indicates a very decent valuation of ABN.
  • Compared to the rest of the industry, the Price/Earnings ratio of ABN is on the same level as its industry peers.
  • ABN is valuated cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • ABN is valuated reasonably with a Price/Forward Earnings ratio of 9.82.
  • 66.98% of the companies in the same industry are more expensive than ABN, based on the Price/Forward Earnings ratio.
  • ABN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.02
Fwd PE 9.82
ABN.AS Price Earnings VS Forward Price EarningsABN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABN.AS Per share dataABN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ABN's earnings are expected to grow with 14.11% in the coming years.
PEG (NY)0.9
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y14.11%

6

5. ABN.AS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.52%, ABN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 4.55, ABN has a dividend in line with its industry peers.
  • ABN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

  • The dividend of ABN has a limited annual growth rate of 0.22%.
Dividend Growth(5Y)0.22%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • ABN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP0%
EPS Next 2Y16.56%
EPS Next 3Y14.11%
ABN.AS Yearly Income VS Free CF VS DividendABN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B 30B 40B

ABN.AS Fundamentals: All Metrics, Ratios and Statistics

ABN AMRO BANK NV-CVA

AMS:ABN (3/6/2026, 7:00:00 PM)

27.11

-0.32 (-1.17%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-11
Earnings (Next)05-13
Inst Owners48.45%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap16.70B
Revenue(TTM)9.35B
Net Income(TTM)2.04B
Analysts73.91
Price Target34.44 (27.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend1.46
Dividend Growth(5Y)0.22%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.38%
Min EPS beat(2)-22.97%
Max EPS beat(2)2.21%
EPS beat(4)3
Avg EPS beat(4)-4.09%
Min EPS beat(4)-22.97%
Max EPS beat(4)2.3%
EPS beat(8)6
Avg EPS beat(8)6.36%
EPS beat(12)10
Avg EPS beat(12)17.27%
EPS beat(16)14
Avg EPS beat(16)36.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.73%
Min Revenue beat(2)-5.2%
Max Revenue beat(2)-2.25%
Revenue beat(4)0
Avg Revenue beat(4)-2.87%
Min Revenue beat(4)-5.2%
Max Revenue beat(4)-1.33%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)7
Avg Revenue beat(12)0.07%
Revenue beat(16)11
Avg Revenue beat(16)4.55%
PT rev (1m)5.95%
PT rev (3m)17.17%
EPS NQ rev (1m)8.1%
EPS NQ rev (3m)4.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.19%
Revenue NQ rev (1m)-2.49%
Revenue NQ rev (3m)-2.94%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE 11.02
Fwd PE 9.82
P/S 1.79
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 0.62
EV/EBITDA N/A
EPS(TTM)2.46
EY9.07%
EPS(NY)2.76
Fwd EY10.19%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS15.17
BVpS43.89
TBVpS43.89
PEG (NY)0.9
PEG (5Y)N/A
Graham Number49.29
Profitability
Industry RankSector Rank
ROA 0.49%
ROE 7.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.78%
GM N/A
FCFM N/A
ROA(3y)0.59%
ROA(5y)0.51%
ROE(3y)9.02%
ROE(5y)8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.34%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 3.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.89%
EPS 3Y7.87%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y12.28%
EPS Next 2Y16.56%
EPS Next 3Y14.11%
EPS Next 5Y11.16%
Revenue 1Y (TTM)-2.43%
Revenue growth 3Y3.28%
Revenue growth 5Y1.47%
Sales Q2Q%0.85%
Revenue Next Year6.03%
Revenue Next 2Y6.01%
Revenue Next 3Y5.43%
Revenue Next 5Y2.7%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ABN AMRO BANK NV-CVA / ABN.AS FAQ

Can you provide the ChartMill fundamental rating for ABN AMRO BANK NV-CVA?

ChartMill assigns a fundamental rating of 3 / 10 to ABN.AS.


What is the valuation status for ABN stock?

ChartMill assigns a valuation rating of 5 / 10 to ABN AMRO BANK NV-CVA (ABN.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for ABN AMRO BANK NV-CVA?

ABN AMRO BANK NV-CVA (ABN.AS) has a profitability rating of 2 / 10.


What is the financial health of ABN AMRO BANK NV-CVA (ABN.AS) stock?

The financial health rating of ABN AMRO BANK NV-CVA (ABN.AS) is 1 / 10.


Can you provide the expected EPS growth for ABN stock?

The Earnings per Share (EPS) of ABN AMRO BANK NV-CVA (ABN.AS) is expected to grow by 12.28% in the next year.